Saku Reunanen

Saku Reunanen is a PhD student at the University of Helsinki, where he focuses on developing new small-molecule drug candidates. His doctoral research aims to improve levodopa treatment for Parkinson’s disease by preventing the unwanted degradation of the drug by gut microbes.